Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-21

Clinical Trial Update: Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer

View source ↗

Summary

A completed trial comparing oral versus infusion chemotherapy in recurrent ovarian cancer assessing impact on quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwestern University | Conditions: Ovarian Cancer, Malignant Tumor of Peritoneum | Status: COMPLETED